Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Royal Philips (Koninklijke Philips N.V., NYSE: PHG) is a health technology company whose news flow centers on diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics and personal health. Company announcements frequently highlight AI-enabled systems, new product launches and strategic portfolio moves, giving investors and observers insight into how Philips develops and positions its health technology offerings.
Recent Philips news has featured AI-powered innovations in image-guided therapy and diagnostic imaging, such as LumiGuide 3D Device Guidance for light-based navigation during minimally invasive procedures, DeviceGuide for AI-assisted tracking of heart valve repair devices, and Verida, a detector-based spectral CT system with AI integrated across the imaging chain. The company also reports advances in MRI through its BlueSeal Horizon 3.0T platform and extended partnerships in neuroimaging, such as the integration of Cortechs.ai quantitative analytics into Philips MR workflows.
News items also cover enterprise informatics and cloud-based solutions, including the launch of Philips Management 15, a web-based diagnostic viewer that delivers full radiology capabilities through a browser and interfaces with AI tools and interactive reporting. In addition, Philips communicates on long-term partnerships with health systems, monitoring agreements and large-scale deployments of its Azurion image-guided therapy systems.
Corporate and portfolio developments appear regularly in the news stream. Examples include the agreement to acquire SpectraWAVE Inc. to expand intravascular imaging and physiology solutions, and the completed carve-out of the Philips Emergency Care business, which now operates as Heartstream under a Philips brand license. Earnings-related releases and Form 6-K summaries provide context on comparable order intake, sales trends, margins, productivity programs and outlook.
Investors and healthcare professionals following PHG news can use this page to track product introductions, AI and imaging milestones, strategic transactions and quarterly performance updates that shape Philips’ role in global health technology.
On October 12, 2022, Royal Philips (NYSE: PHG) provided a financial update for Q3 2022, highlighting a significant impact from supply chain challenges. Group sales are projected at approximately EUR 4.3 billion, marking a 5% decline. The Diagnosis & Treatment segment anticipates a low-single-digit decline, while Connected Care expects a mid-teen drop. A EUR 1.3 billion goodwill impairment charge for the Sleep & Respiratory Care business is expected due to revised forecasts. Philips aims for a better second half of 2022, despite ongoing supply chain disruptions.
On October 10, 2022, Philips received the prestigious gold-level Touchstone Award from the Center for Health Design for its innovative Ambient Experience behavioral health rooms at Children's Medical Center Dallas. This solution enhances care for pediatric patients experiencing behavioral health issues by integrating technology to improve staff-patient interactions. The recognition follows multiple other awards for the design, underscoring Philips' commitment to enhancing healthcare delivery through evidence-based design. The solution aims to de-escalate challenging behaviors and improve overall patient experience.
On September 30, 2022, Royal Philips (NYSE: PHG) announced the appointment of Roy Jakobs as the new President and CEO, effective October 15, 2022, succeeding Frans van Houten. The Supervisory Board expressed confidence in Jakobs’ ability to drive the company’s focus on health technology and improve shareholder value. Van Houten reflected on his 12-year tenure and expressed gratitude towards his colleagues. Jakobs emphasized his commitment to innovation and transparency as he prepares to lead Philips into its next chapter.
Philips Sonicare has partnered with actress Marsai Martin as its first Come Back Coach to promote the importance of self-care, particularly through oral hygiene. Martin emphasizes the role of a confident smile in self-esteem and encourages the use of Philips One by Sonicare electric toothbrush. This toothbrush is designed for effective daily routines, featuring a SmarTimer™ and Quadpacer. Priced from $24.99, it is available in various colors. A survey reveals 93% of Americans are seeking self-improvement, with 83% focusing on oral health.
Royal Philips (NYSE: PHG) presented its latest innovations in cardiology at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting held in Boston from September 16-19, 2022. Key highlights include global consensus data advocating the use of intravascular ultrasound (IVUS) for peripheral vascular disease procedures. Philips emphasized the importance of its technology in improving patient outcomes and efficiencies in clinical settings. Notable products showcased include the VeriSight Pro catheter and the EchoNavigator 4.0 imaging system, enhancing diagnostic and therapeutic capabilities in cardiac care.
Philips has announced the upcoming launch of FetView, a cloud-based fetal ultrasound image sharing software designed for obstetrics and gynecology. This vendor-neutral platform will allow physicians to access ultrasound images and patient data in real-time, promoting enhanced diagnostic confidence and better patient communication. FetView aims to streamline workflows, improve departmental efficiency, and reduce costs by enabling secure sharing of medical data. The software will be showcased at the ISUOG World Congress from September 16-18, 2022, in London.
Philips Foundation, RAD-AID International, and Philips have announced a multi-year partnership to enhance access to diagnostic ultrasound services across 10 countries, targeting 50 million people. The initiative will utilize a 'train-the-trainer' model to educate local health workers through real-time distance learning and simulated procedures. This collaboration focuses on improving healthcare in underserved regions by deploying ultrasound devices and providing remote training to address gaps in diagnostic imaging.
Zylorion Health Inc. has announced the appointments of Jeroen Tas to its Board of Directors and Ted Goldstein to its Digital Health Advisory Committee. Tas, former Chief Innovation and Strategy Officer at Philips, and Goldstein, ex-Chief Artificial Intelligence Officer at Elevance Health, bring extensive experience in health technologies and bioinformatics. CEO Peter Silverstone expressed enthusiasm over their addition, highlighting their potential contributions to Zylorion's mission of delivering innovative therapies for mental health challenges, including MDD, TRD, and PTSD.
Philips has achieved significant milestones in developing its Spectral Angio CT suite, integrating breakthrough spectral CT imaging technology for enhanced treatment procedures. Notably, Leiden University Medical Center has joined Philips' clinical network to explore the technology's potential in interventional oncology. Additionally, positive study results were presented at CIRSE 2022, showcasing improved lung tumor biopsy guidance using spectral CT. A collaboration with the University of Pennsylvania aims to enhance tumor treatment effectiveness in real-time.
Royal Philips' subsidiary, Philips Respironics, has issued a voluntary alert regarding certain CPAP and Bi-Level PAP masks with magnetic headgear clips. These masks should not be used by or near individuals with implanted metallic medical devices due to potential magnetic interference. The company has distributed over 17 million such masks and received 14 reports of adverse effects linked to the magnets, including pacemaker failure and seizures. Users are advised to discontinue use and consult a physician for alternatives.